Accelerating Breakthrough Discoveries in Brain Disease
It is the mission of ZelosDx to provide researchers with novel blood testing tools that accelerate breakthrough discoveries
The Problem
Neurologic disease and brain trauma affect the lives of over 100 million patients in the US alone, accounting for over $1.3 trillion of nondiscretionary healthcare spending every year. Unfortunately, this market is challenged by failed drug trials, ineffective treatments, and delayed diagnoses. A critical missing piece is the lack of low-cost blood testing products that can be used as tools to enable breakthrough discoveries in research and drug development where failures to advance drugs to the market have been notorious.
